SecBot SecBot
SECBOTREPLAY Home › Report › BCAX

BCAX · Bicara Therapeutics announced it will report its Q4 and full-year 2025…

Bicara Therapeutics Inc. · PRESS-RELEASE filed Mar 23, 2026 at 08:30 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 23, 2026 at 08:30 ET

Bicara Therapeutics announced it will report its Q4 and full-year 2025 financial results on March 30, 2026, along with a business update. The company will host a conference call to discuss the results, but no financial data or material updates were released in this press release.

  • Bicara Therapeutics will report Q4 and full-year 2025 financial results on March 30, 2026, before market open.
  • A conference call is scheduled for 8:30 a.m. ET on the same day to discuss results and business updates.
  • No financial figures, guidance, or material operational updates were disclosed in this announcement.
  • The company remains in clinical-stage development with ficerafusp alfa as its lead asset.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access